Announcements Trials
Browse Landscape

Phase

Phase NA 26Phase 2 25Phase 1 12Phase 1/2 11Phase 3 5Phase EARLY_PHASE1 4Phase 4 1Phase 2/3 1

Status

Recruiting 86Active not recruiting 45Not yet recruiting 41Completed 24Terminated 10Suspended 6Enrolling by invitation 5Withdrawn 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 2Genitourinary 1CNS 1

Conditions

Neoplasms 2Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1

Interventions

irinotecan sucrosofate 1Temozolomide 1Radiation 1Irinotecan 1Immunoconjugates 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × 90 days × Clear all
NCT04488224 2026-05-19

Nano-X IG

University of Sydney

Phase EARLY_PHASE1 Withdrawn
Tumor-Agnostic

Neoplasms

NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

SynerGene Therapeutics, Inc.

Phase EARLY_PHASE1 Withdrawn
CNS

Central Nervous System Neoplasms

NCT06708936 2026-05-08

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study

Kousai Bio Co., Ltd.

Phase EARLY_PHASE1 Withdrawn
Genitourinary

Carcinoma, Renal Cell

NCT07052760 2026-04-29

Imaging of Solid Tumors Using DLL3 SPECT

University of California, San Francisco

Phase EARLY_PHASE1 Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡